miller syndrome |
Disease ID | 1608 |
---|---|
Disease | miller syndrome |
Definition | Miller syndrome, also known as postaxial acrofacial dysostosis, is a rare genetic disorder characterized by craniofacial malformations occurring along with abnormalities of the arms, hands and/or feet. Craniofacial abnormalities include underdevelopment of the cheekbones (malar hypoplasia), an abnormally small lower jaw (micrognathia), incomplete closure of the roof of the mouth (cleft palate), small, protruding, “cup-shaped” ears; and/or absence of tissue (colobomas) from the lower eyelids. Limb abnormalities may include incomplete development, webbing (syndactyly), and/or closure or absence of certain fingers and/or toes; and/or improper development and/or abnormal fusion of bones in the forearms (radioulnar synostosis), causing the forearms to appear unusually short. Additional physical abnormalities can occur in some cases. Intelligence is not affected. Miller syndrome is inherited as an autosomal recessive trait caused by mutations in theDHODHgene.Miller syndrome was first described in the medical field between 1969 and 1979 through several independent reports. The disorder is refereed by several names derived from some of the physicians who first reported the disorder including M. Miller, H.R. Wiedemann, and E. Genee. Some researchers believe that Miller syndrome represents a distinct entity under the broader term of “postaxial acrofacial dysostosis,” which would include other disorders with similar and overlapping craniofacial and limb abnormalities, but ultimately distinct symptoms. - NORD Reference: NORD |
Synonym | genee-wiedemann acrofacial dysostosis genee-wiedemann syndrome miller syndrome (disorder) miller syndromes miller's syndrome millers syndrome poads poads syndrome postaxial acrofacial dysostosis postaxial acrofacial dysostosis (poads) postaxial acrofacial dysostosis (poads) syndrome postaxial acrofacial dysostosis syndrome wildervanck-smith syndrome |
Orphanet | |
OMIM | |
UMLS | C0265257 |
SNOMED-CT | |
Curated Gene | Entrez_id | Symbol | Resource(Total Genes:1) |
Inferring Gene | (Waiting for update.) |
Text Mined Gene | (Waiting for update.) |
Locus | (Waiting for update.) |
Disease ID | 1608 |
---|---|
Disease | miller syndrome |
Integrated Phenotype | (Waiting for update.) |
Text Mined Phenotype | (Waiting for update.) |
Disease ID | 1608 |
---|---|
Disease | miller syndrome |
Manually Symptom | (Waiting for update.) |
Text Mined Symptom | (Waiting for update.) |
Manually Genotype(Total Text Mining Genotypes:0) |
---|
(Waiting for update.) |
All Snps(Total Genotypes:11) | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
snpId | pubmedId | geneId | geneSymbol | diseaseId | sourceId | sentence | score | Year | geneSymbol_dbSNP | CHROMOSOME | POS | REF | ALT |
rs201230446 | 19915526 | 1723 | DHODH | umls:C0265257 | UNIPROT | Sanger sequencing confirmed the presence of DHODH mutations in three additional families with Miller syndrome. | 0.361357209 | 2010 | DHODH | 16 | 72014641 | C | T |
rs201230446 | 22967083 | 1723 | DHODH | umls:C0265257 | BeFree | In conclusion, the G202A and R346W mutation causes deficient protein stability, and the R135C mutation does not affect stability but impairs the substrate-induced enzymatic activity, suggesting that impairment of DHODH activity is linked to the Miller syndrome phenotype. | 0.361357209 | 2012 | DHODH | 16 | 72014641 | C | T |
rs201230446 | NA | 1723 | DHODH | umls:C0265257 | CLINVAR | NA | 0.361357209 | NA | DHODH | 16 | 72014641 | C | T |
rs201947120 | NA | 1723 | DHODH | umls:C0265257 | CLINVAR | NA | 0.361357209 | NA | DHODH | 16 | 72023536 | C | T |
rs201947120 | 22967083 | 1723 | DHODH | umls:C0265257 | BeFree | In conclusion, the G202A and R346W mutation causes deficient protein stability, and the R135C mutation does not affect stability but impairs the substrate-induced enzymatic activity, suggesting that impairment of DHODH activity is linked to the Miller syndrome phenotype. | 0.361357209 | 2012 | DHODH | 16 | 72023536 | C | T |
rs267606765 | NA | 1723 | DHODH | umls:C0265257 | CLINVAR | NA | 0.361357209 | NA | DHODH | 16 | 72012084 | G | A,C |
rs267606766 | NA | 1723 | DHODH | umls:C0265257 | CLINVAR | NA | 0.361357209 | NA | DHODH | 16 | 72017043 | G | A |
rs267606767 | NA | 1723 | DHODH | umls:C0265257 | CLINVAR | NA | 0.361357209 | NA | DHODH | 16 | 72021211 | G | A,C |
rs267606767 | 22967083 | 1723 | DHODH | umls:C0265257 | BeFree | In conclusion, the G202A and R346W mutation causes deficient protein stability, and the R135C mutation does not affect stability but impairs the substrate-induced enzymatic activity, suggesting that impairment of DHODH activity is linked to the Miller syndrome phenotype. | 0.361357209 | 2012 | DHODH | 16 | 72021211 | G | A,C |
rs267606768 | NA | 1723 | DHODH | umls:C0265257 | CLINVAR | NA | 0.361357209 | NA | DHODH | 16 | 72022386 | C | T |
rs267606769 | NA | 1723 | DHODH | umls:C0265257 | CLINVAR | NA | 0.361357209 | NA | DHODH | 16 | 72021201 | C | T |
GWASdb Annotation(Total Genotypes:0) | |
---|---|
(Waiting for update.) |
GWASdb Snp Trait(Total Genotypes:0) | |
---|---|
(Waiting for update.) |
Mapped by lexical matching(Total Items:0) |
---|
(Waiting for update.) |
Mapped by homologous gene(Total Items:0) |
---|
(Waiting for update.) |
Chemical(Total Drugs:0) | |
---|---|
(Waiting for update.) |
FDA approved drug and dosage information(Total Drugs:0) | |
---|---|
(Waiting for update.) |
FDA labeling changes(Total Drugs:0) | |
---|---|
(Waiting for update.) |